Exagen Inc —— 季度财务数据 (NASDAQ:XGN)

Financials

经营活动产生的现金 363 K-10.67 M-2.88 M2.94 M-3.01 M -13.63 M 投资活动产生的现金 -146 K-107 K-209 K-275 K-35 K -626 K 融资活动产生的现金 -216 K-64 K21.93 M2.95 M-384 K 24.43 M 自由现金流 217 K-10.78 M-3.09 M2.67 M-3.06 M -14.27 M

新闻

KeyBanc因定价压力下调Exagen目标价

KeyBanc cuts Exagen stock price target on pricing headwinds

Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-03-11

Canaccord因利润率前景将Exagen目标价下调至10美元

Exagen stock price target lowered to $10 by Canaccord on margin outlook

BTIG因营收前景下调Exagen目标价至9美元

BTIG cuts Exagen stock price target to $9 on lower revenue outlook

William Blair维持Exagen股票跑赢大盘评级

Exagen stock maintains Outperform rating at William Blair

Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates

ExagenQ1每股收益及营收逊于预期

Exagen earnings missed by $0.01, revenue fell short of estimates